Objectives: To evaluate peripheral insulin stimulated glucose uptake as a predictor for increase in blood pressure in hypertension-prone men. Design: A follow-up study 5 years after a primary investigation that included an euglycaemic hyperinsulinaemic clamp to evaluate insulin sensitivity. Subjects: Thirty-two men with a family history of hypertension (relatives) and 22 men with no hypertension in the family (controls). All were normotensive and had a normal glucose tolerance. Main outcome measures: Change in blood pressure over 5 years and its relation to the values obtained in the basal investigation. Results: Systolic and diastolic blood pressure increased in both groups during the 5 years, but dia-
Introduction
Essential hypertension is associated with insulin resistance and hyperinsulinaemia, 1, 2 and earlier studies from our group and others have shown that normotensive offspring of patients with essential hypertension also have decreased insulin stimulated glucose uptake compared to subjects with no hypertension in the family. [3] [4] [5] [6] [7] This might indicate that insulin resistance precedes the rise in blood pressure. However, to our knowledge no prospective study has demonstrated the predictive value of insulin resistance with respect to glucose metabolism for the development of hypertension. The aim of the present study was to evaluate the importance of insulin-stimulated peripheral glucose uptake for the blood pressure level 5 years later in a follow-up stolic blood pressure increased more in relatives than in controls (11 mm Hg vs 5 mm Hg, P ‫؍‬ 0.03). The change in diastolic blood pressure was correlated to basal BMI (r ‫؍‬ 0.43, P ‫؍‬ 0.02) only in controls. There were no correlations between the change in blood pressure during the 5 years and basal glucose disposal nor to any of the other basal parameters in either relatives or controls. Conclusions: Insulin sensitivity did not predict the change in blood pressure during the 5 years either in hypertension-prone men or in controls, nor did anthropometrical measurements, basal and stimulated insulin and maximal oxygen uptake. The blood pressure increase was related to basal BMI only in controls. Journal of Human Hypertension (2001) 15, 781-785 study of male offspring to hypertensive patients and age-matched controls from families with no history of hypertension. The initial study of these two groups demonstrated that the sons of the hypertensive subjects were more insulin resistant and had lower maximal oxygen uptake compared to the controls.
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Subjects and methods
Subjects
Two groups of healthy men were investigated. The selection procedures have been described in detail earlier. 3 Briefly, one group included sons of families with a documented family history of essential hypertension in 1/both parents, 2/one parent and one grandparent on the same side or 3/one parent and one sibling (relatives). The other group included sons of families with no family history of hypertension (controls). Subjects included in the first investigation were aged 25-46 years, had a supine diastolic blood pressure consistently below 90 mm Hg and a normal oral glucose tolerance test. Subjects with a serum ␥-glutamyl transpeptidase above 0.80 kat/l were excluded. None of the subjects had any disease that was judged to influence the results of the study and none of them had been on any regular medication for at least 12 months before the investigation.
Study design
First investigation: The screening procedure has been described in detail elsewhere. 8 Prior to the investigation all subjects were instructed to adhere to their normal life style and avoid changes in food intake, alcohol consumption and exercise. The subjects were non-smoking and fasting overnight. For the calculation of waist/hip circumference ratio, measurements were made at the umbilicus and iliac crest levels, respectively, with the subject standing erect. Blood pressure was measured using a mercury sphygmomanometer after allowing the subject a 10-min supine rest. The blood pressures given are the average of three measurements, each taken with the subject in the recumbent position. Korotkoff phase V was used for diastolic blood pressure. Blood samples were taken for determination of serum cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-chol), and ␥-glutamyl transpeptidase. An oral glucose tolerance test was performed according to WHO criteria (75 g of glucose). 9 Blood samples for glucose, serum insulin and plasma Cpeptide were drawn before and 40 and 120 min after glucose administration. Men with blood glucose Ͼ7.8 mmol/l at 120 min were regarded as glucose intolerant and were excluded. Immediately after the oral glucose tolerance test a 6-min submaximal exercise test was performed using a bicycle ergometer and a workload of 100-225 W, depending on the subject's weight and reported level of physical activity. The mean heart rate during the last 2 min of the test was used for calculation of maximal oxygen uptake according to a reference table described by Å strand. 10 One to 3 months later a hyperinsulinaemic euglycaemic clamp was performed 3, 11 with measurement of arterial glucose concentration by a glucose oxidase-peroxidase method every fifth minute and a target level of 5.0 mmol/l. The steady-state insulin concentration was about 100 mU/L. Glucose disposal rate (M) was calculated as the amount of glucose infused during the second hour and expressed per kg body weight (mg/kg b.w./min) and the insulin sensitivity index (M/I) as the amount of glucose metabolised per unit plasma insulin (ie, glucose disposal divided by the mean of insulin concentration at 60 and 120 min, multiplied by 100).
The effects of insulin on renal tubular sodium reabsorption and the renin-aldosterone system were studied. 12 Plasma values of aldosterone were determined with radioimmunoassay techniques. 13 The study protocol was approved by the Ethics Committee, Medical Faculty of Lund University, and informed consent was obtained from each individual. This first investigation comprised 39 relatives and 29 controls.
Second investigation: Five years (±2 months) after the first investigation all participants were invited to a new investigation that included blood pressure measurement, anthropometry and laboratory assessments including fasting blood samples for glucose, insulin, C-peptide, cholesterol, triglycerides and HDL-cholesterol as described above. Thirty-two relatives and 22 controls attended this second examination. The drop out was due to inability to attend the investigation for non-medical reasons. The seven subjects in each group that were not reinvestigated were excluded from all calculations.
Statistical analyses
Values are given as median (range). As several of the variables were not normally distributed, nonparametric methods were used for statistical evaluation. The Wilcoxon signed rank test was used for comparison of paired data and Spearman's rank correlation test to calculate correlation coefficients. Logistic regression was used for testing which factor was the strongest predictor for hypertension. The level of significance was taken at a value of P Ͻ 0.05.
Results
Insulin sensitivity index (M/I) and maximal oxygen uptake were lower and triglycerides were higher at the first investigation in relatives compared to controls. The decrease in plasma aldosterone during clamp was also significantly lower in relatives compared to controls (Table 1) .
Systolic and diastolic blood pressure increased in both groups during 5 years follow-up, but diastolic blood pressure increased more in relatives than in controls (11 mm Hg vs 5 mm Hg, P ϭ 0.03). BMI, waist-hip ratio, serum triglycerides, blood glucose and serum cholesterol also increased in both groups, but did not differ between the groups (Table 1) . Cpeptide increased only in relatives, whereas insulin and HDL-cholesterol did not change in either of the groups.
The two populations were divided into subgroups according to the change in or the absolute level of diastolic blood pressure at follow-up. This was defined as an increase in diastolic blood pressure Ͼ5 mm Hg and/or a diastolic blood pressure Ͼ90 mm Hg at follow-up (hypertension category). Fiftythree percent of the relatives and 23% of the controls fulfilled these criteria (P ϭ 0.027).
The change in diastolic blood pressure was correlated to basal BMI in controls (r ϭ 0.43, P ϭ 0.02). There were no correlations either in relatives or in controls between the change in blood pressure during 5 years and basal insulin sensitivity index (slope 0.4; 95% CI −0.9, 1.6 and slope −0.3; 95% CI −0.9, 0.3 respectively) or any of the other basal measurements. In a logistic regression analysis with hypertension category as the nominal variable and heredity for hypertension (relative/control), basal BMI and insulin sensitivity index as response variables, only heredity for hypertension significantly influenced the hypertension category (OR ϭ 3.9, 95% CI 1.1-13.0. P ϭ 0.03). The change in plasma aldosterone during the hyperinsulinaemic euglycaemic clamp did not correlate to the change in blood pressure in any of the two groups. BMI was not correlated to basal plasma aldosterone concentration or change in plasma aldosterone during the hyperinsulinaemic euglycaemic clamp in any of the groups.
Discussion
We have earlier demonstrated that hypertensionprone relatives have lower insulin stimulated glucose uptake and lower maximal oxygen uptake compared to controls; and that these two parameters were related to each other. 3 This was the case also in the subgroups that were included in the present study. The aim of the present study was to investigate whether the level of insulin sensitivity at a time when all subjects were normotensive could predict the blood pressure after 5 years. If so, this would support the hypothesis that insulin resistance per se is a pathogenetic factor for the development of essential hypertension.
The increase in diastolic blood pressure was larger in relatives than in controls, and as many as 53% of the relatives had an increase in diastolic blood pressure of more than 5 mm Hg or had reached a diastolic level of more than 90 mm Hg, compared to 23% of controls. This indicates that the Journal of Human Hypertension subjects defined as relatives really were predisposed to hypertension. When studying normotensive individuals with an inherited disposition for hypertension it is not possible to know the proportion of subjects who have the genetic aberration which eventually will lead to hypertension. It is obvious that this fact interferes with the outcome of the study, especially in relatively small groups of subjects as in our study, and that interpretations should be cautious. Another limitation is the fact that blood pressure was only measured at a single occasion at the second investigation. However, considering that relatives were demonstrated to be more insulinresistant and had a more marked increase in diastolic blood pressure at follow-up, it is reasonable to assume that the present study will adequately reflect the long-term influence of insulin sensitivity on blood pressure in a group of men with genetic disposition for hypertension.
There were no indications that either the level of insulin sensitivity measured with the clamp technique or the fasting or stimulated insulin, or glucose concentrations measured during an oral glucose load test were related to the change in blood pressure over the following 5 years in any of the groups. Initial BMI was related to the change in blood pressure over 5 years only in controls.
In a study of healthy middle-aged individuals insulin resistance was associated with a higher risk for cardiovascular disease and hypertension, taken together, during a 5 year follow-up period. 14 In a study where blood pressure was measured at home and blood lipids and fasting insulin were analysed in 735 individuals with a mean age of 32 years, blood pressure but not insulin predicted hypertension 3 years later. 15 In the San Antonio Heart Study clustering of risk factors associated with the 'meta-bolic syndrome', including high BMI, were more common in those who developed hypertension during the 8-year follow-up period, 16 but only nonobese subjects with high baseline insulin concentrations had an increased incidence of hypertension compared with those with low insulin concentration. In a smaller study, where insulin sensitivity was measured, the conclusion was also that the relationship between high fasting insulin concentration and high diastolic blood pressure was stronger in lean than in obese subjects. 17 In our study the median BMI was 24 -25 in the two groups with a rather wide range, and a significant increase was registered in both groups at follow-up.
In our initial investigation 3 the waist-hip ratio was closely correlated to insulin sensitivity in controls (r ϭ −0.70, P Ͻ 0.0001), but not in relatives. BMI was correlated to M in both groups. In a multivariance analysis maximal oxygen uptake and BMI were significantly correlated to insulin sensitivity and explained 28% and 9% respectively of the variation in M in relatives. The corresponding figures for controls were 49% for waist-hip ratio and 17% for maximal oxygen uptake. In the present followup study the change in diastolic blood pressure was not related to M, waist-hip ratio or maximal oxygen uptake, and BMI was correlated to the change in diastolic blood pressure only in controls. The interpretation of this could be that in men insulin sensitivity is determined by different factors in relatives and controls, but in neither of these groups is insulin sensitivity directly involved in the regulation of blood pressure. The two might be epiphenomenons.
Studies on treatment with metformin, which increases insulin sensitivity, are conflicting concerning the effect on blood pressure, but most controlled studies showed no change in blood pressure in non-diabetic hypertensives. This also seems to contradict the hypothesis of a direct relationship between insulin sensitivity and blood pressure level. [18] [19] [20] [21] We have earlier demonstrated that in spite of an impaired insulin-stimulated glucose uptake the insulin-induced tubular sodium reabsorption is retained in relatives. 12 The suppression of plasma aldosterone observed in controls during the clamp was blunted in relatives, which could suggest a tendency to sodium retention in these subjects. However, we found no relationship between the initial degree of aldosterone suppression and the change in blood pressure during the following 5 years in any of the groups. Recent evidence shows that a local renin-angiotensin system is present in human adipose tissue. 22, 23 The wide variation in BMI in our study groups could hypothetically interfere with the aldosterone concentration and the response of the renin-angiotensin-aldosterone system at increasing insulin concentrations. However, we found no correlation between either basal aldosterone or aldosterone suppression and BMI in any of the two groups.
In conclusion, hypertension-prone relatives showed a greater increase in diastolic blood pressure than controls during 5 years follow-up. The blood pressure increase was not related to initial insulin sensitivity, basal or stimulated insulin release or physical fitness in any of the groups. Basal BMI was a predictor of the blood pressure increase only in controls.
